New cellular therapy offers hope for multiple myeloma patients. Although several effective treatments exist for Multi Myeloma patients with this blood cancer face a disheartening reality: Most will experience relapses over several years, and with each relapse, treatment becomes less effective.
Patients with multiple myeloma may have no symptoms for years. When the disease is active —for example, at the time a patient first seeks medical help or when the disease is at an advanced stage —they may experience bone pain, fatigue and even confusion, among other symptoms. Because the cancer comes from plasma cells that normally help fight infections by secreting antibodies, multiple myeloma also weakens patients’ immune systems, leading to frequent infections.
Jakubowiak, however, is especially excited about the effectiveness of a new cellular therapy called idecabtagene vicleucel (brand name Abecma.